HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NOC/oFQ contributes to age-dependent impairment of NMDA-induced cerebrovasodilation after brain injury.

Abstract
This study characterized the effects of fluid percussion brain injury (FPI) on N-methyl-D-aspartate (NMDA)-induced vasodilation and determined the role of nociceptin/orphanin FQ (NOC/oFQ) in such changes as a function of age and time postinsult. FPI elevated cerebrospinal fluid (CSF) NOC/oFQ from 70 +/- 3 to 444 +/- 56 pg/ml ( approximately 10(-10) M) within 1 h and to 1,931 +/- 112 pg/ml within 8 h, whereas values returned to control levels within 168 h in the newborn pig. In contrast, FPI elevated CSF NOC/oFQ from 77 +/- 4 to 202 +/- 16 pg/ml within 1 h and values returned to control levels within 8 h in the juvenile pig. Topical NOC/oFQ (10(-10) M) had no effect on pial artery diameter but attenuated NMDA (10(-8), 10(-6) M)-induced dilation (9 +/- 1 and 16 +/- 1 vs. 5 +/- 1 and 10 +/- 1%) in both age groups. In the newborn, NMDA-induced pial artery dilation was reversed to vasoconstriction within 1 h post-FPI and responses remained impaired for 72 h, but such vasoconstriction was attenuated by pretreatment with [F/G]NOC/oFQ(1-13)-NH(2) (10(-6) M, 1 mg/kg iv), an NOC/oFQ antagonist (9 +/- 1 and 16 +/- 1 vs. -7 +/- 1 and -12 +/- 1 vs -2 +/- 1 and -3 +/- 1% for control, FPI, and FPI pretreated with the NOC/oFQ antagonist). In contrast, in the juvenile, NMDA-induced vasodilation was only attenuated within 1 h post-FPI and returned to control within 8 h. Such dilation was also partially restored by the NOC/oFQ antagonist. These data indicate that NOC/oFQ contributes to impaired NMDA pial artery dilation after FPI. These data suggest that the greater NOC/oFQ release in the newborn versus the juvenile may contribute to age-related differences in FPI effects on excitatory amino acid-induced pial dilation.
AuthorsW M Armstead
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 279 Issue 5 Pg. H2188-95 (Nov 2000) ISSN: 0363-6135 [Print] United States
PMID11045952 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • (F-G)NOC oFQ(1-13)-NH2
  • Excitatory Amino Acids
  • Narcotic Antagonists
  • Opioid Peptides
  • Peptide Fragments
  • Receptors, Opioid
  • Glutamic Acid
  • N-Methylaspartate
  • nociceptin
  • Nociceptin Receptor
Topics
  • Aging (drug effects, metabolism)
  • Animals
  • Animals, Newborn
  • Arterioles (drug effects)
  • Blood Pressure (drug effects)
  • Brain Injuries (metabolism)
  • Cerebrovascular Circulation (drug effects)
  • Disease Models, Animal
  • Excitatory Amino Acids (metabolism, pharmacology)
  • Female
  • Glutamic Acid (metabolism, pharmacology)
  • Male
  • N-Methylaspartate (metabolism, pharmacology)
  • Narcotic Antagonists
  • Opioid Peptides (cerebrospinal fluid, metabolism, pharmacology)
  • Peptide Fragments (pharmacology)
  • Pia Mater (blood supply, drug effects)
  • Receptors, Opioid
  • Swine
  • Vasoconstriction (drug effects)
  • Vasodilation (drug effects)
  • Wounds, Nonpenetrating
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: